| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/2004 | CN1166443C Betaine product, method for its manufacture, and its use |
| 09/15/2004 | CN1166409C Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 09/15/2004 | CN1166408C Substrate tablet containing trimetzidine capable of long time controlled release after oral application |
| 09/15/2004 | CN1166406C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 09/15/2004 | CN1166403C Multicatalytic protease inhibitors |
| 09/15/2004 | CN1166397C Medicine for treating cardiovascular and cerebrovascular system disease, apoplectic sequel |
| 09/15/2004 | CN1166395C External medicine for curing traumatic injuries |
| 09/15/2004 | CN1166394C Chinese medicine for treating pharynigitis and globus hystericus and its prepn |
| 09/15/2004 | CN1166391C Anti-drunk-enness and sobering up composition and its preparing method |
| 09/15/2004 | CN1166388C Medicine for treating nosal inflammation |
| 09/15/2004 | CN1166385C Chinese herbal medicine composition for treating caries pain and its prepn |
| 09/15/2004 | CN1166384C Medicine for relieving cough and asthma |
| 09/15/2004 | CN1166380C Plaster for treating infantile parotitis and its preparing process |
| 09/15/2004 | CN1166372C Formula of medicine for treating myopia and preparation process thereof |
| 09/15/2004 | CN1166366C Process for producing composite preparation containing nucleic acid |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/15/2004 | CN1166364C Controlled drug delivery system for diltiazem |
| 09/15/2004 | CN1166363C Use of moxonidine for postmyocardial infarction treatment |
| 09/15/2004 | CN1166362C Solution agent of antiallergi medicine contg. levocetirizine |
| 09/15/2004 | CN1166361C Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flashes |
| 09/15/2004 | CN1166360C Long acting injection microsphere combination of naltrexone, its preparation method and application |
| 09/15/2004 | CN1166359C New oral dosage form of Anethol Trithione |
| 09/15/2004 | CN1166353C Amphoteric lipids dispersion body |
| 09/14/2004 | US6791003 Dual adhesive transdermal drug delivery system |
| 09/14/2004 | US6790992 Scyphostatin analogues as SMase inhibitors |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790986 Forming a water insoluble hydroxybenzoic acid salt in aqueous solution, precipitation, suspension in a lower alcohol, adding a tertiary amine base to precipitate pure gabapentin; free of chloride anions |
| 09/14/2004 | US6790984 Process for purifying pravastatin sodium from a fermentation broth |
| 09/14/2004 | US6790980 Tannate compositions and methods of treatment |
| 09/14/2004 | US6790979 Use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in subject with androgen-related affliction |
| 09/14/2004 | US6790966 Having antineoplastic activity; antioxidant activity; and inhibit dna topoisomerase ii enzyme |
| 09/14/2004 | US6790963 E-isomeric fullerene derivatives |
| 09/14/2004 | US6790960 Compounds |
| 09/14/2004 | US6790957 Converting tertiary hydroxy group of a triazole antifungal compound into a phosphate group to improve aqueous solubility |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790869 3 tetra- and 1 pentahydroxylated analogs; 1-di-, 1 tri-, 3 tetra- and 1-pentamethoxylated analogs; anticarcinogenic and antiproliferative agents; inhibits cell growth; induced apoptosis |
| 09/14/2004 | US6790868 Non-halogenated phenoxy and/or benzyloxy substituted phenols, antimicrobial compositions containing the same, and methods of using the same |
| 09/14/2004 | US6790867 Combination of flunixin or the meglumine salt with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol |
| 09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
| 09/14/2004 | US6790863 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790859 Therapy or reducing progression of hypertension or damage to a tissue caused by contact with elevated levels of reducing sugars in an animal, comprising administering to the animal an effective amount of thiazolium compounds |
| 09/14/2004 | US6790858 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone |
| 09/14/2004 | US6790855 Two compounds, one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered |
| 09/14/2004 | US6790853 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | US6790850 Thiazolo(4,5-d)pyrimidine compounds |
| 09/14/2004 | US6790849 Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants |
| 09/14/2004 | US6790848 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
| 09/14/2004 | US6790847 Topical application of cetirizine and loratadine |
| 09/14/2004 | US6790846 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 09/14/2004 | US6790843 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/14/2004 | US6790842 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS |
| 09/14/2004 | US6790841 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| 09/14/2004 | US6790839 Inducing proliferation of bone marrow cells |
| 09/14/2004 | US6790837 Ribavirin syrup formulations |
| 09/14/2004 | US6790836 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 09/14/2004 | US6790835 Bicyclic macrolide derivatives |
| 09/14/2004 | US6790834 Cytostatic agents |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790465 Composition and method for treating snoring |
| 09/14/2004 | US6790463 Peroxidation reaction products of an alkene, such as geraniol; penetrating solvent, such as dimithyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. |
| 09/14/2004 | US6790462 Phosphorus and from greater than 1.3 to less than 2.2 parts by weight calcium per part by weight phosphorus; directly compressible into tablets |
| 09/14/2004 | US6790459 Methods for treating diabetes via administration of controlled release metformin |
| 09/14/2004 | US6790450 Use of coxiella bacteria to treat autoimmune disease |
| 09/14/2004 | US6790440 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine) |
| 09/14/2004 | US6789546 Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject |
| 09/14/2004 | CA2459869A1 A system for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer |
| 09/14/2004 | CA2456569A1 Benzoazine mono-n-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/14/2004 | CA2280708C Cetp activity inhibitors |
| 09/14/2004 | CA2274389C Paroxetine tablets and process to prepare them |
| 09/14/2004 | CA2264549C Spirocyclic dopamine receptor subtype ligands |
| 09/14/2004 | CA2254079C Androstene derivatives |
| 09/14/2004 | CA2130115C Prevention of retinal injury and degeneration by specific factors |
| 09/14/2004 | CA2124455C Indole derivatives, process for producing the same and medicinal uses of the same |
| 09/14/2004 | CA2116829C Use of a pregnane derivative |
| 09/14/2004 | CA2104339C N-acetonylbenzamides and their use as fungicides |
| 09/11/2004 | CA2458288A1 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
| 09/10/2004 | WO2004077367A1 Tetracyclic sulfenamide compound |
| 09/10/2004 | WO2004077062A2 Method for selecting a candidate drug compound |
| 09/10/2004 | WO2004076693A1 Tailored treatment suitable for different forms of mastocytosis |
| 09/10/2004 | WO2004076674A1 Delivery of sirna to cells using polyampholytes |
| 09/10/2004 | WO2004076663A1 INDUCTION OF METHYLATION OF CpG SEQUENCE BY dsRNA IN MAMMALIAN CELL |
| 09/10/2004 | WO2004076640A2 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
| 09/10/2004 | WO2004076637A2 Cell-polymer fiber compositions and use thereof |
| 09/10/2004 | WO2004076632A2 Methods of screening for trpm5 modulators |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076491A1 Medicinal composition for ophthal use containing acetylated hyaluronic acid |
| 09/10/2004 | WO2004076471A1 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076451A1 Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors |
| 09/10/2004 | WO2004076450A1 Pyrazolopyridine derivates |
| 09/10/2004 | WO2004076445A2 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 09/10/2004 | WO2004076443A1 Amorphous form of losartan potassium |
| 09/10/2004 | WO2004076442A1 Polymorphs of losartan |